Key result
COMT LL genotype linked to ~47% more vasodilatory shock and increased AKI after cardiac surgery.
Why the study?
Does the COMT LL genotype increase the risk of shock and acute kidney injury in patients after cardiac surgery?
Cohort (n=260)
Does the COMT LL genotype increase the risk of shock and acute kidney injury in patients after cardiac surgery?
Absolute Event Rate: 69% vs 47%
p-value: p=0.033
The COMT LL genotype is an independent risk factor for vasodilatory shock and acute kidney injury following cardiac surgery.
COMT LL genotype flags higher post-bypass shock and AKI risk; extends genetic associations but leaves causal targeting unproven.
Enzymatic pathways involving catechol-O-methyltransferase (COMT) catabolize circulating catecholamines. A G-to-A polymorphism in the fourth exon of the COMT gene results in a valine-to-methionine amino acid substitution at codon 158, which leads to thermolability and low ("L"), as opposed to high ("H"), enzymatic activity. We enrolled 260 patients postbypass surgery to test the hypothesis that COMT gene variants impair circulating catecholamine metabolism, predisposing to shock and acute kidney injury (AKI) after cardiac surgery. In accordance with the Hardy-Weinberg equilibrium, we identified 64 (24.6%) homozygous (LL), 123 (47.3%) heterozygous (HL), and 73 (28.1%) homozygous (HH) patients. Postoperative catecholamines were higher in homozygous LL patients compared with heterozygous HL and homozygous HH patients (P < 0.01). During their intensive care stay, LL patients had both a significantly greater frequency of vasodilatory shock (LL: 69%, HL: 57%, HH: 47%; P = 0.033) and a significantly longer median duration of shock (LL: 18.5 h, HL: 14.0 h, HH: 11.0 h; P = 0.013). LL patients also had a greater frequency of AKI (LL: 31%, HL: 19.5%, HH: 13.7%; P = 0.038) and their AKI was more severe as defined by a need for renal replacement therapy (LL: 7.8%, HL: 2.4%, HH: 0%; P = 0.026). The LL genotype associated with intensive care and hospital length of stay (P < 0.001 and P = 0.002, respectively), and we observed a trend for higher mortality. Cross-validation analysis revealed a similar graded relationship of adverse outcomes by genotype. In summary, this study identifies COMT LL homozygosity as an independent risk factor for shock, AKI, and hospital stay after cardiac surgery. (ClinicalTrials.gov number, NCT00334009).
No takes yet. Share an insight, caveat, or question.
Haase‐Fielitz et al. (2009) conducted a cohort in Postbypass surgery (n=260). COMT LL genotype vs. COMT HL and HH genotypes was evaluated on Vasodilatory shock (p=0.033). The COMT LL genotype was associated with a significantly greater frequency of vasodilatory shock (69% vs 47% for HH; P=0.033) and acute kidney injury (31% vs 13.7%; P=0.038) after cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: